These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2833953)

  • 1. Evidence for the involvement of calmodulin in natural cytotoxicity using a range of calmodulin antagonists of varying potency and improved specificity.
    Rees RC; Parker S; Platts A; Blackburn MG; MacNeil S
    Biosci Rep; 1987 Oct; 7(10):771-5. PubMed ID: 2833953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of calmodulin in human natural killer cell activity.
    Moon TD; Morley JE; Vessella RL; Lange PH
    Scand J Immunol; 1983 Sep; 18(3):255-8. PubMed ID: 6622981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the anti-proliferative effects of calmodulin antagonists in cultured cells--W7 derivatives of improved cytostatic potential.
    Barton CH; Blackburn GM; Rees R; Bleehen SS; Senior JH; Munro DS; MacNeil S
    Carcinogenesis; 1987 Jul; 8(7):919-23. PubMed ID: 3594725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The naphthalenesulphonamide calmodulin antagonist W7 and its 5-iodo-1-C8 analogue inhibit potassium and calcium currents in NG108-15 neuroblastoma x glioma cells in a manner possibly unrelated to their antagonism of calmodulin.
    Caulfield MP; Robbins J; Sim JA; Brown DA; Mac Neil S; Blackburn GM
    Neurosci Lett; 1991 Apr; 125(1):57-61. PubMed ID: 1649984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restorative effects of defective autologous lymphocyte cytotoxicity by calmodulin antagonists.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Biochem Biophys Res Commun; 1985 Oct; 132(2):620-7. PubMed ID: 4062941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of calmodulin-stimulated phosphodiesterase activity by vasoactive intestinal peptide.
    Barnette MS; Weiss B
    J Neurochem; 1985 Aug; 45(2):640-3. PubMed ID: 2989433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of calcium antagonists in the human natural killer cell-mediated cytotoxicity.
    Waschke K; von Baehr R; Wolf G
    Allerg Immunol (Leipz); 1987; 33(1):27-34. PubMed ID: 2954444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitor of calmodulin and calmodulin dependent enzyme].
    Hidaka H; Naito Y
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1732-8. PubMed ID: 9788175
    [No Abstract]   [Full Text] [Related]  

  • 9. Calmodulin antagonists of improved potency and specificity for use in the study of calmodulin biochemistry.
    MacNeil S; Griffin M; Cooke AM; Pettett NJ; Dawson RA; Owen R; Blackburn GM
    Biochem Pharmacol; 1988 May; 37(9):1717-23. PubMed ID: 2897857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of cortisol inhibition of human natural killer cell activity: effects of calcium entry blockers and calmodulin antagonists.
    Gatti G; Masera R; Cavallo R; Sartori ML; Delponte D; Carignola R; Salvadori A; Angeli A
    Steroids; 1987 Jun; 49(6):601-16. PubMed ID: 3453566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist.
    Solovera JJ; Alvarez-Mon M; Casas J; Carballido J; Durantez A
    J Immunol; 1987 Aug; 139(3):876-80. PubMed ID: 2439598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-dependent natural killer and calcium-independent natural cytotoxic activities in an IL-2-dependent killer cell line.
    Richards AL; Djeu JY
    J Immunol; 1990 Nov; 145(9):3144-9. PubMed ID: 2120346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calmodulin antagonists on immune mouse lymphocytes.
    Wolberg G; Zimmerman TP
    Mol Pharmacol; 1984 Sep; 26(2):286-92. PubMed ID: 6482875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell cytotoxicity: role of calmodulin.
    Rochette-Egly C; Tovey MG
    Biochem Biophys Res Commun; 1984 Jun; 121(2):478-86. PubMed ID: 6203532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP.
    Lanefelt F; Ullberg M; Jondal M; Fredholm BB
    Med Biol; 1983; 61(6):324-30. PubMed ID: 6328136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the involvement of calmodulin in mouse sperm capacitation.
    Si Y; Olds-Clarke P
    Biol Reprod; 2000 May; 62(5):1231-9. PubMed ID: 10775171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and calmodulin mediation of growth hormone-releasing hormone release from the rat hypothalamus in vitro.
    Honegger J; D'Urso R; Besser GM; Grossman AB
    Endocrinology; 1991 Jul; 129(1):11-6. PubMed ID: 1675985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of newly synthesized sulfonamide derivatives on calmodulin-dependent phosphodiesterase activity and their modulation of the external ATP-dependent permeability change in mammalian cultured cells.
    Kitagawa T; Sato S; Tamaki T; Oda T; Akamatsu Y
    Biochim Biophys Acta; 1989 Dec; 987(2):235-8. PubMed ID: 2557928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paramecium calcium channels are blocked by a family of calmodulin antagonists.
    Ehrlich BE; Jacobson AR; Hinrichsen R; Sayre LM; Forte MA
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5718-22. PubMed ID: 2456578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.